E
Eywa Pharma
Develops generic pharma products based on robust technologies
About Eywa Pharma
Eywa Pharma is a rapidly growing global generic pharmaceuticals company dedicated to providing affordable, high-quality medicines to patients worldwide. The company addresses critical challenges such as aging populations, rising healthcare costs, supply interruptions, and accessibility to essential medications. Eywa Pharma serves a diverse range of clients, including healthcare providers, pharmacies, and distributors, operating primarily in the generic pharmaceuticals market. The business model focuses on the development, manufacturing, and distribution of generic drugs, ensuring continuous access to essential medicines at competitive prices. Revenue is generated through the sale of these generic pharmaceuticals across various international markets. Eywa Pharma's seasoned team, with deep industry experience, is passionately committed to the company's mission of making high-quality medicines available globally.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Singapore, Singapore
- Employees
- 24
- Open positions
- None listed
- Dealroom signal
- 61.2/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCEquity / VC | Jan 2019 | $0 | — | InnoVen Capital | — |
| SERIES A✓Equity / VC | Oct 2016 | $30M | $120M | Eight Roads Ventures · F-Prime · Envest Capital Partners · Fidelity International Strategic Ventures | — |
Growth signals
Latest recorded traffic for Eywa Pharma is 650 monthly website visits, up 282.4% over the last three months. Eywa Pharma's team declined 7.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Eight Roads Ventures
F-Prime
Envest Capital Partners
Fidelity International Strategic Ventures
InnoVen Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Eywa Pharma on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Eywa Pharma’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







